Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary

<div>The serum CA19-9 level kept rising in spite of three cycles of XELOX and three cycles of gemcitabine/cisplatin and returned to the reference range following surgical resection of the abdominal wall mass.</div>

Case Reports in Pathology

fig4

Figure 4

Figure 4: Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary 

Figure 4 | Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary 